Quiz

Stimulants and Psychosis Risk in ADHD

Edited by

12/22/2025

Reference
Mantas M. Stimulant treatment for ADHD associated with psychosis and BD. Psych Congress Network. September 25, 2025. Accessed December 22, 2025.

Related Content

Sponsored

Partner Resource

Meet Leo, a Pediatric Candidate for a Nonstimulant ADHD Treatment

10/30/2026

See the profile of a hypothetical 8-year-old patient living with ADHD who may benefit from a nonstimulant, once-daily treatment.

See the profile of a...

10/30/2026

Psych Congress Network

Sponsored

Partner Resource

Meet Maya, a High School Student Who May Benefit From ADHD Treatment With All-Day Coverage

10/30/2026

See the patient profile for Maya, a full-time student whose unique needs may make her a good candidate for this ADHD treatment.

See the patient profile for...

10/30/2026

Psych Congress Network

A young boy doing homework as his mom watches

Sponsored

Partner Resource

A Tool to Help Caregivers of Your Pediatric Patients With ADHD Learn and Communicate Their Needs

10/30/2026

Offer caregivers of your pediatric patients with ADHD a helpful brochure that can aid them in discussing their child’s ADHD and learn about a nonstimulant treatment option.

Offer caregivers of your...

10/30/2026

Psych Congress Network

Sponsored

Partner Resource

The Report Card Is in. What Is It Saying About ADHD?

10/30/2026

A report card may be just one clue to how ADHD is affecting a child. Explore discussion starters and a nonstimulant treatment option to support conversations with parents.

A report card may be just one...

10/30/2026

Psych Congress Network

NEW FROM PSYCH CONGRESS NP INSTITUTE

Clinical Pearls

Making Lifestyle Interventions Practical and Accessible in MDD Care

10/29/2026

Michael Asbach, DMSc, PA-C; Arwen Podesta, MD

Arwen Podesta, MD, DFAPA, Psych Congress Steering Committee Member, and Mike Asbach, DMSc, PA-C, Co-Chair, Psych Congress PA Institute, discuss practical strategies for incorporating nutrition and exercise recommendations into psychiatric...

Arwen Podesta, MD, DFAPA, Psych...

10/29/2026

Psych Congress NP Institute

Clinical Pearls

Addressing Lifestyle Factors in Major Depressive Disorder

10/23/2026

Michael Asbach, DMSc, PA-C; Arwen Podesta, MD

How can clinicians incorporate lifestyle interventions into major depressive disorder (MDD) treatment alongside pharmacotherapy?

How can clinicians incorporate...

10/23/2026

Psych Congress NP Institute

Clinical Pearls

Exploring the Role of Dual-Mechanism and Multimodal Antidepressants in MDD Treatment

10/13/2026

Kristian Dambrino, DNP, APRN, MSN

Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.

Kristian Dambrino, DNP,...

10/13/2026

Psych Congress NP Institute

Stimulants and Psychosis Risk in ADHD

NEW FROM PSYCH CONGRESS NP INSTITUTE

HMP Global Products

Events